Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents
Abstract Background The identification of biomarkers that predict susceptibility to major depressive disorder and treatment response to antidepressants is a major challenge. Vortioxetine is a novel multimodal antidepressant that possesses pro-cognitive properties and differentiates from other conven...
Main Authors: | Jessica A. Waller, Sara Holm Nygaard, Yan Li, Kristian Gaarn du Jardin, Joseph A. Tamm, Aicha Abdourahman, Betina Elfving, Alan L. Pehrson, Connie Sánchez, Rasmus Wernersson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | BMC Neuroscience |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12868-017-0376-x |
Similar Items
-
Hypomanic switch during vortioxetine treatment: a case report
by: Efruz Pirdoğan Aydın, et al.
Published: (2019-01-01) -
The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease
by: I. V. Miliukhina
Published: (2020-10-01) -
Comparison of the efficacy of the multimodal serotonergic antidepressants trazodone and vortioxetine in the treatment of patients with endogenous depression: A meta-analysis of double-blind randomized placebo-controlled trials
by: D. S. Danilov
Published: (2017-03-01) -
Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
by: Marcin Siwek, et al.
Published: (2022-03-01) -
Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review
by: Marcin Siwek, et al.
Published: (2021-05-01)